Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Ceesay Abraham, Chief Executive Officer of Rapport Therapeutics, Inc. (NASDAQ:RAPP), executed a series of stock sales totaling $328,436 on July 14, 2026. The transactions were carried out under a Rule 10b5-1 trading plan established on March 27, 2026, and involved the disposition of 8,210 shares across two separate blocks. The sales occurred at pri…
Wolverine World Wide Inc. (NYSE: WWW) director Jeffrey M. Boromisa executed a sale of 25,000 shares on July 13, 2026, totaling $453,500. The transaction, conducted under a Rule 10b5-1 trading plan adopted in March 2026, reduces his indirect holdings through JELCO Investment Co LLC. This activity unfolds against a backdrop of improved financial metr…
United Airlines maintained guidance for full-year adjusted earnings per share at the top end of its prior $9 to $11 range, saying robust travel demand and higher fares should blunt the impact of a renewed rise in fuel costs. The airline reported stronger-than-expected second-quarter results but provided a third-quarter profit forecast that fell sho…
Certara, Inc., a leader in model-informed drug development, will release its Q2 2026 financial results before market open on August 4th, 2026, followed by a management conference call. The company provides biosimulation and regulatory solutions to the global biopharmaceutical industry.
RxSight, an ophthalmic medical device company specializing in adjustable intraocular lenses for cataract surgery, announced that Aziz Mottiwala will become President and CEO, succeeding Ron Kurtz, M.D., who will continue as Chief Medical Officer. The leadership change aims to leverage Mottiwala's commercial expertise to accelerate growth and market…
Plexus Corp. announces the release date of its fiscal third quarter 2026 earnings on July 29, 2026, followed by a management conference call on July 30. The company provides a webcast link and details, highlighting its role in designing and manufacturing complex products across aerospace/defense, healthcare/life sciences, and industrial sectors.
FTAI Infrastructure Inc. announced its plan to release second quarter 2026 financial results on August 5, 2026, followed by a management conference call on August 6, 2026. The company primarily invests in critical infrastructure assets across rail, ports and terminals, and power and gas sectors. The disclosure includes standard forward-looking stat…
Richardson Electronics, Ltd. announced that it will release its Q4 fiscal year 2026 financial results on July 22, 2026, followed by a conference call on July 23. The company manufactures engineered solutions and components serving various markets including alternative energy, healthcare, and communications.
Royalty Pharma plc announced it will report its Q2 2026 financial results on August 5, 2026, with a conference call and webcast scheduled prior to market open. The company, a leading buyer of biopharmaceutical royalties, will provide details on its financial performance including its portfolio of royalties on commercial products and development-sta…
EverQuote, Inc., a leading provider of AI-powered growth solutions for property and casualty insurance providers, announced it will release its second quarter 2026 financial results after market close on August 3, 2026, followed by a conference call and webcast to discuss performance and outlook.
Joseph Paul C, Executive Vice President of Global Sales at Akamai Technologies Inc. (NASDAQ: AKAM), executed a stock sale totaling $392,987 on July 15, 2026. The transaction involved the disposition of 3,100 shares at a price of $126.77 per share. The sale was conducted under a Rule 10b5-1 trading plan adopted by Mr. Joseph on March 4, 2026. Follow…
Edison International (NYSE:EIX) director Peter J. Taylor executed a sale of 500 shares on July 13, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan. The transaction occurs as the utility stock trades near its 52-week high, following a significant 60% gain over the past year. This sale comes amid broader market scrutiny regarding the compan…
AST SpaceMobile said it intends to privately offer $1.0 billion of convertible senior notes due 2034, triggering a roughly 10% decline in its shares during after-hours trading. The unsecured notes will accrue interest payable semiannually, be convertible at the company's election into cash, Class A common stock or a mix of both, and include an init…
Jeremy Prahm, Chief Investment Officer at Finance of America Companies Inc. (NASDAQ: FOA), sold 6,000 shares of the company's Class A Common Stock on July 13, 2026. The transaction was executed at a weighted average price of $25.5987 per share, totaling $153,592. This sale was conducted under a Rule 10b5-1 trading plan adopted on December 22, 2025.…
Hallador Energy Co. (NASDAQ:HNRG) director Barbara Ann Sugg executed a purchase of 5,000 shares on July 14, 2026, totaling $85,648. The acquisition price ranged between $17.129 and $17.1299 per share. This transaction occurs as the company navigates a significant earnings miss for the first quarter of 2026 and engages in strategic capacity contract…
ACM Research, Inc. will release its second quarter 2026 financial results before the U.S. market opens on August 7, 2026. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results. ACM Research specializes in semiconductor process equipment, offering solutions to enhance manufacturing efficiency and product yield.
Pacific Biosciences (PacBio) announced it will report its second quarter 2026 financial results on August 5, 2026, and hold a conference call to discuss these results. PacBio is a life science technology company specializing in advanced sequencing solutions for genetic research across multiple sectors.
Pulmonx Corporation, a Nasdaq-listed company specializing in minimally invasive treatments for lung disease, announced it will release its second quarter 2026 financial results on July 29, 2026, followed by a management conference call. The company is known for its Zephyr Endobronchial Valve and related pulmonary assessment technologies aimed at tr…
Applied Digital Corporation announced its upcoming fiscal fourth quarter and full year 2026 earnings conference call to be held on July 27, 2026, where the company will discuss its financial results and operations. The company specializes in sustainably engineered data centers focused on AI, networking, and blockchain workloads. Management will pro…
Mobia Medical, a Nasdaq-listed medical device firm focused on stroke recovery technologies, announced the appointment of Reza Zadno, Ph.D., to its Board of Directors. Dr. Zadno brings over 35 years of medical technology leadership experience, including leading companies through IPOs and commercial expansions. His addition is expected to support Mob…
Forward Industries, a Solana-focused digital asset treasury company, announced the appointment of Michael Ashe, Galaxy Digital's Chief Strategy Officer, to its Board of Directors. Ashe's extensive experience in crypto and finance is expected to bolster Forward's growth and governance as it expands its Solana ecosystem investments and operations.
MYR Group Inc., a leading specialty electrical contractor in North America, announced it will release its second quarter 2026 earnings on July 29, 2026, followed by a conference call on July 30. The company provides transmission & distribution and commercial & industrial electrical contracting services across the United States and Canada, serving d…
Teekay Corporation Ltd. and Teekay Tankers Ltd., collectively known as the Teekay Group, have published their 2025 Sustainability Report detailing their fleet operations including crude oil transport and marine services. The report underscores their continued commitment to sustainability in the shipping and energy sectors, with fleets operating glo…
MaxCyte, a Nasdaq-listed cell-engineering company, announced it will report its financial results for the second quarter of 2026 after market close on August 12, 2026. The company will host a conference call to discuss the results with investors and analysts, leveraging its position in the advanced cell therapy technology sector.
Teladoc Health Inc., a leading global virtual care company, announced it will release its second quarter 2026 financial results after market close on July 29, 2026, followed by a conference call at 5:00 p.m. ET to discuss the results. Access details for the call and replay are provided to investors and interested parties.
